Provista Blog > [Video] Dr. Elayne Arterbery: Breast Cancer Diagnostic Challenges
Dr. Elayne Arterbery, a radiation oncologist discusses the challenges that surround patients with abnormal imaging findings, as well as those further confounded by dense breast tissue.
"One of the challenges for women that are faced with an abnormal mammogram is the timeframe to get additional imaging, ultrasound, [or] biopsy. There is a waiting period that you don't know whether or not you have a malignancy," says Dr. Arterbery.
To learn more about the challenges surrounding early detection, watch Dr. Arterbery's video below:
Dr. Arterbery also discusses how she has utilized Videssa® Breast in her practice for women with abnormal imaging results in this video featured on WNEM.com.
We need to add complementary breast cancer diagnostic tool to the current standard-of-care imaging techniques. By doing so, we will improve the ability to identify biological cues in a woman's bloodstream that may be indicative of the presence or absence of breast cancer. Ground-breaking technologies in the form of a blood-based approach will help imaging rule-out breast cancer in women with abnormalities and dense breast tissue, while also aiding imaging to more accurately identify breast cancer, increasing the survival rate of the disease.
Are you interested in learning more about blood-based approaches to complement current imaging methods? Check out our free guide below!
At Provista Diagnostics, our mission is to develop world-class diagnostic tests for indications in breast and gynecologic cancers. As a leading diagnostics company, our aim is to create, produce and market innovative solutions for unmet clinical needs. Our products and services help to diagnose diseases and inform better clinical decisions, thus enhancing women’s health and quality of life. We do this in a responsible and ethical manner with a commitment to excellence in every aspect of our business.